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Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells damage target
membranes through the membrane assembly of structural and functional pores
(reviewed in references 1-4). Granules isolated from these cells contain proteins
that are cytolytic and membrane-active, indicating that the lytic apparatus of
these effector cells resides in their cytoplasmic granules (5-13). Recently, a pore-
forming protein (PFP,' also named perforin or cytolysin) that mediates this type
ofmembrane damage has been isolated from lymphocyte granules and partially
characterized (13-16).
Since intact granules isolated from effector cells are cytolytic, it is not clear
how the lytic polypeptides are transferred from granules to target membranes.
Moreover, no information is available on the intermediate steps involved in the
assembly ofthe pore by soluble PFP/perforin that has been secreted by effector
cells or released from the granules. To understand better the assembly mecha-
nism, we describe here some of the intermediate steps involved in this cytolytic
event. We also report on the role ofcertain modulatory factorssuch as pH, Ca",
serum (and serum proteins), and proteoglycans on the lytic activity of granules
and of soluble PFP/perforin. During cell killing, these factors may play a
regulatory function on the membranolytic activity produced by CTL and NK
cells.
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Materials and Methods
CTLL, Granule Isolation and Purification of PFP. The cytotoxic T lymphocyte cell line
(CTLL) R8 was maintained in IL-2-containing medium (16). Granules were isolated by
centrifugation of nucleus-free cell lysate through a Percoll gradient, as described (12),
with the exception that a discontinuous Percoll gradient of 14 ml of 1.08 g/ml, 7 ml of
1.05 g/ml, and 7 ml of 1.03 g/ml was used. 10 ml of cell lysate (2-3 x 107 cell
equivalents/ml) were layered on top and the tube was centrifuged at 39,000 g for 18.5
min in a Sorvall SS34 rotor. Fractions of 1 ml were collected and numbered from the
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top. Membrane-free granule extracts were obtained by incubation of granule fractions
with 0.5 M NaKHP04, pH 7.4, 10 mM benzamidine on ice (15), and purified PFP/perforin
was obtained as described previously (13, 15, 16). Intact granules were obtained by high-
speed centrifugation of Percoll fractions (180,000 g for 2 h), which resulted in the
sedimentation of granules as a fluffy layer on top of the firm Percoll pellet. This material
was gently aspirated into relaxation buffer (16) and immediately used afterwards as a
source of intact granules.
Microassay System.
￿
The hemolytic activity of the fractions was assessed by a turbidi-
metric microassay as described (17). Briefly, 5-20 pl of hemolytically active samples were
incubated with 200 ,u1 of PBS, pH 7 .4, containing 1 mM CaC12 and SRBC (5 X 10''/ml).
After a 30 min incubation at 37"C, the microtiter plates were read at A7oo. One hemolytic
unit (HU) was defined as the amount of material required to achieve 50% hemolysis (Hso)
of 5 X 10' SRBC/ml in the presence of 1 mM CaC12 and pH 7 .4 . When buffers of other
compositions were used as specified in the text, the SRBC suspension was always washed
three times in the final buffer immediately before use. In all experiments, the granules
and granule extracts were diluted at least 100-fold with the various buffers described in
the text.
To dissociate the membrane binding and the lytic activities of granule extracts and
purified PFP, SRBC were incubated with active samples on ice for 20 min in Eppendorf
tubes. The cell suspension was then washed three times with ice-cold Ca2'-free PBS by
centrifugation at 4°C to remove unbound proteins. The final cell pellet was resuspended
to original volume with PBS containing 1 mM CaC12 and aliquots of 200 t1 of cell
suspension were added to microtiter wells on ice. The A,oo, determined at this point as a
control, showed virtually no hemolysis. The remaining wells were incubated for additional
30 min at 37'C before final A7oo reading of the wells. Inhibitors (5-20,1) were added to
the hemolytically active samples and allowed to incubate for 20 min on ice before addition
of SRBC. To study the effect of inhibitors directly on the pore formation step, the
inhibitors were added to SRBC suspensions that have been exposed to membrane-active
proteins and have been washed free of unbound proteins; incubation with inhibitors at
this step was done on ice for 20 min before cells were warmed up to 37°C and A700 was
determined. The serum used in the text refers to heat-inactivated pooled human serum
(Bio-Bee, Boston, MA), which had a protein concentration of 9.9 mg/ml. High-density
lipoprotein (HDL) subpopulation 3 from normal human plasma was purified essentially
as described (18). Human plasma low-density lipoproteins (LDL) were generouslyprovided
by Dr. R. Montgomery (19). Both HDL3 and LDL were shown to be electrophoretically
pure before use. Chondroitin sulfate used consisted ofmixed isomers (grade III) and types
A, B, and C (Sigma Chemical Co., St. Louis, MO). Heparin (grade II) was also obtained
from Sigma Chemical Co.
The pH dependence of the hemolytic activities (Fig. 2) was performed using 25 mM
Hepes buffer containing 0.14 M NaCl and 5 mM CaC12, adjusted to the final pH given in
the text with Tris-base. To determine the effect of pH on membrane binding and lytic
activities (Fig. 4), SRBC were allowed to bind to granule extracts on ice for 20 min in
four different combinations of Hepes-Tris buffer, containing either 10 MM CaC12 Or 0
CaC12 (supplemented with 1 mM EGTA), with the final pH adjusted to 6.0 or 7.4, as
indicated in the text. After incubation, cells were washed three times in ice-cold buffer
containing the following recipes: (a) for cells initially incubated on ice with Hepes-Tris
buffer, without CaC12 (and 1 mM EGTA), pH 6, the washing buffer consisted of Hepes-
Tris buffer, 10 mM CaCl2, adjusted to pH 6 or 7.4 (as noted in the text); (b) for initial
incubation with Hepes-Tris buffer, 10 mM CaC12, pH 6, cells were washed with Hepes-
Tris buffer, no CaC12, pH 6 or 7 .4; (c) for initial incubation with Hepes-Tris buffer, no
CaC12, pH 7.4, cells were washed with Hepes-Trisbuffer, 10 mM CaC12, pH 6 or 7.4; and
(d) for initial incubation with Hepes-Tris buffer, 10 mM CaC12, pH 7.4, cellswere washed
with Hepes-Tris buffer, 10 mM CaC12, pH 6 or 7 .4. After the last wash, cells were
resuspended to original volume with the same washing buffers and incubated at 37°C for
30 min, and the wells were then read at A7oo.
The Ca2' dependence of the hemolytic activities (Fig. 3) was performed using the(,
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FIGURE 1 .
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Profile of subcellular markers of CTLL-
R8 cell lysate separated by a discontinuous Percoll
gradient. Hemolysis (a), serine esterase (b) and proteo-
glycan (c) microassays were performed as described in
Materials and Methods, using 20 wl of cell sample per
well. Data points represent average of duplicates. (c)
An absorbance of 0.2 (A41u to A0a) corresponds to
7.5 wg of chondroitin sulfate and 6 ug of heparin. (b)
The background A410 observed was due to Percoll and
was not subtracted.
following buffer: 10 mM Hepes, 0.15 M NaCl, 0 .8 mM MgC12; 0.5 mM EGTA, with pH
adjusted to pH 7.4 or 6.8 with Tris-base as indicated in the text. The various concentra-
tions of free Ca" were adjusted with CaC12 following calculations obtained with a
computer program kindly provided by Dr. A. Aderem of The Rockefeller University.
The program made use ofconstants and relationships published elsewhere (20).
Microassays for protein content and enzymatic activities (serine esterase, ,B-glucuroni-
dase, acid phosphatase, and succinate dehydrogenase) were performed essentially as
described (21). Granules of CTL and lymphocytes with high NK-like activity have recently
been shown to be markedly enriched for a serine esterase activity (21, 22), and a microassay
for this marker has since been used as a convenient granule marker (21). Briefly, the
reaction mixture for serine esterase assay consisted of 10 141 of enzyme sample and 200,ul
of substrate (2 x 10' M N,a-benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT; Calbi-
ochem-Behring Corp., La Jolla, CA), 2.2 x 10' M nitrobenzoic acid, 0.1 M Tris-HCI,
pH 8). After incubation for 30 min at 25°C, the A410 of the wells was determined.
An automated microassay for proteoglycans was modified from a published procedure
(23). The assay was based on quantitative binding of the dye dimethylene blue (DMB)
(Polysciences, Inc., Warrington, PA) by proteoglycans. 20 A.1 of sample were mixed with
200 II,I of the dye solution (0.25% by weight of DMB, 3% formic acid) and the product
was immediately read as the difference between A410 and A6so. The differential absorbance
reading allows the partial elimination of the background due to the presence of Percoll.
Heparin and chondroitin sulfate (grade III, mixed isomers; Sigma Chemical Co.) were
used as standards.
Results
Granule Isolation: Presence of Serine Esterase and Proteoglycans in Granules of
CTLL. Granules from CTLL-R8 cells were enriched by subcellular fractiona-
tion, as assessed by hemolytic and serine esterase activities (Fig. 1). Granules of
CTLL-R8 cells also contained proteoglycans (Fig. 1), a finding consistent with
recent reports (24-26) that have described the presence of proteoglycans in the
granules of NK cells. In addition to the granule markers shown in Fig. 1, granule
fractions were also enriched for ,Q-glucuronidase and acid phosphatase activities
(data not shown) . Granules could be separated from mitochondrial, lysosomal,
and plasma membrane fractions based on the differential distribution of succinate
dehydrogenase, a-glucuronidase, acid phosphatase, 5'-nucleotidase, alkaline1374
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pH dependence of hemolysis by intact gran-
ules (0), granule extracts (O), and purified PFP (A) ob-
tained from the Mono Q column. Active material was
obtained as describedin Materialsand Methods. 2 HU of
sample/20 dal were used per well in triplicates.
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FIGURE 3.
￿
Ca"dependence of hemolytic ac-
tivities of granule extracts (O, 0) and intact
granules (A, A). (0, A) pH 7.4; (O, p) pH 6.8-
2 HU of active sample were used per well in
triplicates.
phosphodiesterase (reference 21; enzyme profiles not shown here). The enriched
granule fractions were then used for functional assays as described next.
Membranolytic Activities of Granules and PFP/Perforin Show Different Require-
mentsfor Ca2' and pH.
￿
It has previously been shown (13) that intact granules,
isolated from NK-like cells, lyse targets without the need to undergo granule
rupture or release ofgranule contents into the supernatant before their contact
with cells. To study this property in further detail, we performed experiments
using granules in their intact form that have been isolated by subcellular frac-
tionation and have been washed free of lysed granule material by high-speed
centrifugation (referred to as intact granules). The hemolytic activity of intact
granules was then compared with that of granule proteins that have been
solubilized from the granule core by using high salts (referred to as solubilized
granule proteins). As shown in Figs. 2 and 3, the hemolytic activities of intact
granules and solubilized granule proteins showed different dependence curves
for Ca2+ and pH. Intact granules were only hemolytically active at pH >6.6, in
contrast tosolubilizedgranuleproteins that werehemolyticallyactive inabroader
range of pH (activity observed in the pH range 6-8) (Fig. 2). The pH optimum
for both these hemolytic activities, however, was close to neutral pH (7.0-7.4)
(Fig. 2). As expected, the purified PFP obtained from the Mono Q column
produced a pH dependence profile similar to that ofsolubilized granule proteinsYOUNG ET AL.
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(Fig. 2). Soluble granule proteins also required lower amounts of free Ca2+ to
produce the same amount of hemolysis as compared with that required by intact
granules present in equivalent hemolytic units (Fig. 3). For 2 HU of solubilized
granule proteins, H5o was achieved at 100 AM of free Cat+, whereas intact
granules required 300 ,uM to produce H5o undersimilar experimental conditions
(Fig. 3). These observations suggest that intact granules may require an additional
Ca2+ and pH-dependent step to effect cell lysis, an event that can be distinguished
from the Ca2+ and pH-dependent lysis produced by granule proteins. The results
presented here also demonstrate that lowering the pH blocks the lytic activity of
the granules.
The inhibitory effect on the hemolytic activities associated with lowering the
pH of the medium could be attributed in part by interference of low pH with
the Ca2+ requirement. This inference was supported by the following observa-
tions. The hemolytic activity of soluble granule proteins was examined as a
function of the Cat+ concentration at the two fixed pH of 7.4 and 6.8 (Fig. 3).
Lowering pH from 7.4 to 6.8 shifted the hemolytic curve to the right (Fig. 3),
indicating that higher concentrations of free Ca2+ were required at pH 6.8 to
attain the same levels of hemolysis attained at pH 7 .4. A dichotomy of effects
was again observed depending whether intact granules or solubilized granule
proteins were used as the active samples. With intact granules, the inhibitory
effect of lowering the pH was only partially reversed by an increase in the
concentration of Ca21; thus, even increasing Ca2+ to 4.5 mM, the total hemolytic
activity observed at pH 6.8 was lower than that obtained at pH 7 .4 (Fig. 3). At
pH 6, the hemolytic activities associated with both intact granules and soluble
granule proteins were completelyabolished and could not be activated even with
10 mM CaC12. This inhibitory effect was reversible since raising the pH again
from 6 to 7 .4 promptly restored the hemolytic activity. Similar results were
obtained with purified PFP.
Dissociation ofMembrane Binding and Lytic Activities ofPFP/Perforin.
￿
We next
studied the possibility that PFP may need to bind to target membranes prior to
its insertion into the bilayer to form a functional pore. To distinguish membrane
binding from pore insertion, we investigated conditions in which PFP binds to
target membranes without necessarily inflicting membrane damage. SRBC were
incubated with solubilized granule proteins and purified PFP/perforin on ice
(Fig. 4). Hemolysis was not observed under these conditions. However, the same
treated SRBC, washed three times with ice-cold buffer to remove any residual
unbound PFP in the medium, completely lysed upon subsequent incubation at
37°C (Fig. 4). These results indicate that PFP must have bound to erythrocyte
membranes on ice but were incapable of either membrane insertion or pore
formation. Hemolysis also occurred when SRBC bound with PFP on ice were
subsequently incubated at room temperature (20-22°C), rather than 37°C .
However, the kinetics of lysis observed at room temperature was 3-5 fold slower
than that observed at 37'C. Thus, binding of PFP to lipid membranes is
temperature-insensitive and appears to precede the temperature-dependent,
membrane insertion/pore-formation stage that leads to cell lysis.
We next studied separately the Ca2' and the pH dependence of the membrane-
binding and pore-insertion steps (Fig. 4). Membrane binding by PFP occurred1376
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FIGURE 4. Dissociation of membrane binding from
pore-insertion activities associated with PFP in granule
extracts. The conditions for the experiment are outlined
in Materials and Methods. Initial incubation refers to
exposure of SRBC to samples on ice for 20 min under
theconditions indicatedin thegraph, followedby washing
and resuspension of cell pellet in the indicated buffer
(final incubation), andsubsequent incubation at 37'C for
30 min before determination of A7oo. Experiments were
performedin triplicates, with 10 HU of granule extracts
applied to each well. (O) Initial incubation: on ice, 0 Cas+,
pH 6.0; final incubation: 37°C, 10 mM Cas+ VH 6.0 or
7.4. (p) Initial incubation: on ice, 10 mM Cas , pH 6.0;
final incubation: 37°C, 0 Ca
2+, pH 6.0 or 7.4. (®) Initial
incubation: on ice, 0 Ca2+,pH 7.4; finalincubation: 37°C,
7.4
￿
6.0
￿
10 mM Ca", pH 6.0 or 7.4. (a) Initial incubation: on ice,
pH OF FINAL INCUBATION
￿
10 mM Ca", pH 7.4; final incubation: 37°C, 10 mM
Ca", pH 6.0 or 7.4.
CONCENTRATION OF INHIBITOR
(wq/ml)
FIGURE 5. Inhibition of hemolytic activity of
granule extracts by serum, LDL, and HDLs. The
concentration of protein in the undiluted serum
used was 9.9 mg/ml. 60 HU of granule extract
were applied in triplicates to each well under the
conditions outlined in MaterialsandMethods.The
concentration of inhibitor corresponds to the final
concentration of each inhibitor after addition of
theSRBC volume. Controlincubation with buffer
didnot produce any inhibitor (not shown).
only at neutral pH (pH >6.6) and in the presence of submillimolar amounts of
Ca" (free Cat' >50 pM). PFP did not bind to membranes at pH 7 .4 in the
absence of Ca
2+ (with 1 mM EGTA) nor at pH 6 in the presence of 10 mM Ca2+
(Fig. 4). Alternatively, SRBC that effectively bound PFP on ice (at pH 7 .4 in the
presence of 10 mM Ca2+) did not lyse upon subsequent incubation at 37°C if
Ca
2+ was deleted or if the pH was lowered to pH 6 during the subsequent
temperature-sensitive stage (Fig. 4). These results indicate that both a neutral
pH environment and the presence of submillimolar amounts of Ca2' are required
for both membrane binding and pore insertion by PFP.
Selective Inhibition ofMembrane Binding Activity of PFP.
￿
Given our ability to
distinguish between the stages of membrane binding and pore insertion associ-
ated with PFP, we next investigated the mechanisms ofaction ofseveral inhibitors
of PFP. Serum and serum lipoproteins have recently been shown to inhibit the
lytic activity of PFP isolated from a mouse CTLL (27). In accord with these
results, < 1 % human serum inhibited completely the hemolytic activity of 112
HU of CTLL-R8 PFP (Fig. 5). Human LDL and HDL3 at microgram levels also
produced a remarkable dose-dependent inhibition of the hemolytic activity (Fig.Effect on:
YOUNG ET AL.
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TABLE I
Effects ofSerum, HDLs, LDL, and Heparin on the Binding and the Pore
Insertion Stages during Hemolysis by GranulePFP*
Percenthemolysis
Control Serum HDL LDL Heparin
Membrane binding*
￿
100
￿
6
￿
7
￿
0
￿
5
Pore insertion*
￿
100
￿
95
￿
91
￿
93
￿
98
* 5 HU of purified PFP in 10 pi were incubated with 10 pl of serum, HDL or
LDL (at final 50 pg/ml each), or heparin (1 mg/ml) in triplicate wells for 20
min on ice. SRBC (200 pl)were addedto each well andan additional incubation
of 40 minat 37 °C was made before readingof the wellsat A700-
5 HU of purified PFP in 10 pl were added to 200 pl of SRBC suspension in
PBS containing 1 mM CaCl2 .The mixture was incubated on ice for 20 min.
Cells were then washed in ice-cold buffer three times and resuspended to
original volumes. 10 pl of inhibitor, from stocks of 0.4 mg/ml, or 10 pl of
control PBS were addedto each well. The microtiter plate was incubated with
agitation first at 4°C for 20 min, followed by incubation at 37'C for 30 min.
Data points represent averageof triplicates. Similar resultswere obtained with
total solubilized granule proteins.
5). In our hands, LDL was much more effective than HDLs in producing the
same level ofinhibition (Fig. 5). The inhibitory effect on PFP mediated by serum,
LDL, and HDLs occurred only at the stage of membrane binding, as evidenced
by the following observations: SRBC treated with PFP on ice in the presence of
one of these inhibitors did not lyse upon subsequent incubation at 37 0C even
under optimal conditions of Ca2+ and pH (Table I). However, SRBC that had
bound PFP on ice in the absence of any inhibitor lysed effectively upon subse-
quent incubation at 37°C even when serum, HDLs, and LDL were present
during this last incubation (Table I). These results indicate that the serum
lipoproteins inhibit only the bindingof PFP to membranes, probably by compet-
ing with lipidbilayers for lipid-binding domain(s) of PFP. Our results also suggest
that the lipophilic domain(s) of PFP are only accessible when PFP is free in
solution but that these domains become masked after the attachment of PFP to
lipid bilayers. Further experiments are necessary to show whether serum lipo-
proteins may account entirely for the inhibitory effect of whole serum on PFP.
In marked contrast to the action of these lipoproteins, albumin, for example,
had no inhibitory effect on PFP (data not shown).
As noted, granules ofCTLL-R8 cells contain proteoglycans. It is possible that
these highly acidic molecules bind to PFP in the granules to form a stable and
inactivecomplex. We tested the effects ofheparin and chondroitin sulfate (mixed
isomers and types A, B, and C) on the hemolytic activity mediated by PFP (Fig.
6). Heparin alone produced partial inhibitory effect only at 0.5 mg/ml, whereas
chondroitin sulfate was totally ineffective on PFP (Fig. 6). Like the serum
lipoproteins HDL and LDL, heparin at these concentrations only interfered with
membrane binding by PFP (Table I). Addition of heparin to SRBC that have
already bound PFP on ice did not inhibit lysis of these cells upon subsequent
incubation at 37°C (Table 1).1378
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FIGURE 6. Inhibition of hemolytic activity of
granule extracts and purified PFP by proteogly-
cans. 60 HU of solubilized granuleproteins (O, L)
or purified PFP (0, A) were applied in triplicates
perwell and were incubatedwith heparin or chon-
droitin sulfate(mixed isomers) as described in Ma-
terials and Methods. The concentration of inhibi-
torrefers to the final concentration, afteraddition
ofSRBC. Results obtained with chondroitin sulfate
A, B, or C were similar to that obtained with the
mixed isomers.
Discussion
To understand better the mechanism by which the lymphocyte PFP/perforin
monomers assemble into transmembrane lesions, we have attempted here to
define the intermediate steps involved in this type oflytic assembly. At least two
intermediate events involved in the lytic assembly of membrane lesions can be
resolved by these experiments that have not been described previously. We have
shown that PFP binds to erythrocyte membranes under conditions (on ice) that
do not lead to membrane damage. The lytic step produced by membrane-bound
PFP occurs only at higher temperatures.
Both membrane binding and pore formation mediated by PFP are dependent
on the presence ofsubmillimolar amounts ofCa"and neutral pH. A modulatory
effect of pH on the lytic activity of CTL granules was also recently reported by
Criado etal. (11). The strict requirements forneutralpH and millimolar amounts
of Ca" in the expression of membranolytic activity would ensure that PFP is
packaged in the granules of killer cells in an inactive form, since these compart-
mentsarethought to be acidic innature and lowin free Cat+. Itis also noteworthy
to point out that the effect of pH on PFP is totally reversible between pH 6 and
8, precluding the possibility that PFP that has been stored in an acidic microen-
vironment (granules) would be completely inactivated. The role of pH in the
assembly of membrane lesions by PFP is not clear at this time. H+ appears to
interfere first with Ca2' binding by PFP and at high levels directly but reversibly
inactivates PFP.
The membrane-binding and pore-insertion steps are differentially susceptible
to various inhibitors. We have found that serum and the serum components
HDL and LDL inhibit membrane binding by PFP in a dose-dependent manner
without interfering with pore insertion by membrane-bound PFP. Presumably
the serum lipoproteins compete for lipid-binding domain(s) ofPFP, rendering it
inactive to bind to lipid bilayers. This mechanism may play an important protec-
tive function during cell-mediated killing, whereby the extracellular serum could
avoid the accidental injury ofinnocent bystander cells mediated by PFP that has
been released from lymphocytes. During cell killing, the close apposition of
effector/target cell membranes may favor the binding ofthe released PFP to theYOUNG ET AL.
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target membrane. However, any unbound PFP would be rapidly inactivated by
serum, preventing its further cytotoxic use. The lack of effect of serum and
serum HDL and LDL on membrane-bound PFP suggests that once PFP has
bound to bilayers, lysis would proceed to completion in the presence ofa calcium
and neutral pH environment even when the killer cells are no longer in close
attachment with the targets. This possibility would be consistent with previous
reports (28, 29) describing a self-programmed, Ca"-dependent, but killer cell-
independent stage in lymphocyte-mediated killing whichoccurs after contact and
dissolution ofthe lymphocyte from the target.
Recently, proteoglycans ofthe chondroitin sulfate A type have been identified
in the granules of NK cells and shown to be released from cells during cytolysis
(25, 26). As shown here, proteoglycans may also be used as a granule marker for
CTLL. Proteoglycans of CTLL-R8 cell granules can also be visualized on
polyacrylamide gels stained with Alcian Blue, which reveal several bands of
different molecular masses (profile not shown here). Because proteoglycans have
previously been speculated to exert a protective function during cell-mediated
killing, tentatively through their binding to PFP/perforin released from cells
(25, 26), we tested theeffects ofheparin and chondroitin sulfate on the hemolytic
activity mediated by PFP. Only heparin inhibited hemolysis at high concentra-
tions (0.5 mg/ml), whereas chondroitin sulfate (and the three subtypes A, B, and
C)produced no effect in the wide concentration rangetested in ourexperiments.
Heparin at these concentrations also blocked only membrane binding by PFP.
The lack of effect ofchondroitin sulfate and the relatively high concentrations
of heparin required to block the cytolytic function of PFP do not seem to favor
the possibility of a protective function for proteoglycans during cell killing, but
rather suggest that more likely these complex macromolecules play a different
role.
Intact granules isolated from CTL and NK-like lymphocytes have previously
been shown (13) to be hemolytically active. The rupture of granule membranes
and the release ofsoluble granule contents into the supernatant are not required
for the expression of the hemolytic activity. Moreover, the hemolytic activities
of intact granules and solubilized PFP have different requirements for Ca" and
pH, suggesting that intact granules may mediate an additional event to produce
cytolysis that is also Ca
2+_ and pH-dependent. Thus, isolated granules may have
to fuse first with erythrocyte membranes before releasing their contents into the
target cell interior. In close analogy, granules may also have to fuse with
lymphocyte plasma membranes during cell-mediated killing to release granule
contents into the extracellular medium. Ca
21 may be required for this form of
membrane fusion. Previous studies (30) have already shown that stimulation of
lymphocytes with A23187, a calcium ionophore, triggers cells to secrete PFP. It
would be interesting to determine whether the interaction of lymphocytes with
targets also leads to an abrupt rise ofthe cytoplasmic levels of free calcium that
initiates granule fusion and degranulation.
After conjugation ofCTL and NK cells with lysable targets, it is proposed that
at least threedistinctCa2+- and pH-dependent events may berequired to produce
cytolysis: (a) fusion of cytoplasmic granules with the plasma membrane of
lymphocytes, resulting in secretion ofPFP into the immediate area ofcell-to-cell1380
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contact; (b) binding of the released PFP monomers to the target cell membrane;
and (c) assembly of the membrane-bound monomers into functional transmem-
brane pores. It should be noted that at this time we cannot distinguish between
the stages of membrane insertion and pore formation mediated by membrane-
bound PFP. Ifeach monomer molecule forms a functional pore, then membrane
insertion would also be synonymous with pore formation. On the other hand, if
monomers need to self aggregate and polymerize in the plane of the bilayer
before functional pore formation, then membrane insertion would represent
another intermediate step required for the final assembly of the multimeric pore.
Experiments designed to address this issue are currently in progress in our
laboratory.
Summary
Granules isolated from CTL and NK cells contain a cytolytic pore-forming
protein (PFP/perforin). At low temperatures (on ice), PFP binds to erythrocyte
membranes without producing hemolysis. Hemolysis occurs when the PFP-bound
erythrocytes are warmed up to 37-C, which defines a temperature-dependent,
lytic (pore-formation) step distinct from the membrane-binding event. Ca" and
neutral pH are required for both membrane binding and pore formation by
PFP. Serum, LDL, HDL, and heparin inhibit the hemolytic activity of PFP by
blocking its binding to lipid membranes. Lysis by PFP that has bound to
erythrocyte membranes is no longer susceptible to the effect of these inhibitors .
The hemolytic activities associated with intact granules and solubilized PFP show
different requirements for Ca" and pH, indicating that cytolysis produced by
isolated granules may involve an additional step, possibly fusion of granules with
membranes. It is suggested that three distinct Ca"- and pH-dependent events
may be involved during cell killing by CTL and NK cells: (a) fusion ofcytoplasmic
granules of effector cells with their plasma membrane, releasing PFP from cells;
(b) binding of the released PFP to target membranes; and (c) insertion of
monomers and the subsequent formation of lytic pores in the target membrane.
The serum-mediated inhibition of membrane binding by PFP could prevent the
accidental injury of bystander cells by cell-released PFP, but wouldallow cytolysis
to proceed to completion once PFP has bound to the target membrane.
We thank Dr. A. Aderem and R. Montgomery for valuable discussions and for providing
samples of HDL and LDL used in some of our experiments.
Receivedfor publication 21 January 1987.
References
1 . Martz, E. 1984. Lytic granules, adhesion molecules, and other recent insights.
Immunol. Today. 5:254.
2. Henkart, P. A. 1985 . Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev.
Immunol. 3 :31 .
3. Podack, E. R. 1985. The molecular mechanism of lymphocyte-mediated tumor cell
lysis. Immunol. Today. 6:21 .
4. Young, J. D.-E., and Z. A. Cohn. 1986 . Role of granule proteins in lymphocyte-
mediated killing. J. Cell. Biochem. 32:151 .YOUNG ET AL.
￿
138 1
5 . Henkart, P. A., P. J. Millard, C. W. Reynolds, and M. P. Henkart. 1984 . Cytolytic
activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte
tumors.J. Exp. Med. 160:75.
6. Podack, E. R., and P. J. Konigsberg. 1984. Cytolytic T cell granules. Isolation,
structural, biochemical, and functional characterization. J. Exp. Med. 160:695.
7. Millard, P. J., M. P. Henkart, C. W. Reynolds, and P. A. Henkart. 1984. Purification
and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J. Immunol.
132:3197.
8. Blumenthal, R., P. J. Millard, M. P. Henkart, C. W. Reynolds, and P. A. Henkart.
1984. Liposomes as targets for granule cytolysin from cytotoxic large granular
lymphocyte tumors. Proc. Nad. Acad. Sci. USA. 81 :5551 .
9. Young, J. D.-E., C. F. Nathan, and Z. A. Cohn. 1985. Interaction of immune cells
with target cell membranes: is there a common mechanism of killing?J. Cell. Biochem.
9(Suppl.):161 .
10. Masson, D., P. Corthesy, M. Nabholz, andJ. Tschopp. 1985. Appearance of cytolytic
granules upon induction of cytolytic activity in CTL-hybrids. EMBO (Eur. Mol. Biol.
Organ.)J. 4:2533.
11 . Criado, M., J. M. Lindstrom, C. G. Anderson, and G. Dennert. 1985. Cytotoxic
granules from killer cells: specificity of granules and insertion of channels of defined
sizes into target membranes. J. Immunol. 135:4245.
12 . Young,J. D.-E., C. F. Nathan, E. R. Podack, M. A. Palladino, and Z. A. Cohn. 1986.
Functional channel formation associated with cytotoxic T cell granules. Proc. Natl.
Acad. Sci. USA. 83:150.
13 . Young, J. D.-E., H. Hengartner, E. R. Podack, and Z. A. Cohn. 1986. Purification
and characterization of a cytolytic pore-forming protein from granules of cloned
lymphocytes with natural killer activity. Cell. 44:849.
14 . Masson, D., andJ. Tschopp. 1985. Isolation ofa lytic, pore-forming protein (perforin)
from cytolytic T-lymphocytes. J. Biol. Chem. 260 :9069.
15 . Podack, E. R., J. D.-E. Young, and Z. A. Cohn. 1985. Isolation and biochemical and
functional characterization of perforin 1 from cytolytic T cell granules. Proc. Natl.
Acad. Sci. USA. 82:8629.
16 . Young, J. D.-E., E. R. Podack, and Z. A. Cohn. 1986 . Properties of a purified pore-
forming protein (perforin 1) isolated from H2 restricted cytotoxic T cell granules.J.
Exp. Med. 164:144.
17 . Young, J. D.-E., L. G. Leong, M. A. DiNome, and Z. A. Cohn. 1986. A semi-
automated hemolysis microassay for membrane lytic proteins. Anal. Biochem. 154:649.
18. Coetzee, G. A., A. F. Strachan, D. R. van der Westhuyzen, H. C. Hoppe, M . S.
Jeenah, and F. C. de Beer. 1986. Serum amyloid A-containing human high density
lipoprotein 3 : density, size and apolipoprotein composition. J. Biol. Chem. In press.
19. Montgomery, R. R., C. F. Nathan, and Z. A. Cohn. 1986. Effects of reagent and cell-
generated hydrogen peroxide on the properties oflow density lipoprotein. Proc. Natl.
Acad. Sci. USA. 83:6631.
20. Viana, A. L. 1975. Interaction of calcium and magnesium in activating and inhibiting
the nucleoside triphosphatase of sarcoplasmic reticulum vesicles. Biochim. Biophys.
Acta. 410:389.
21 . Young, J. D.-E., L. G. Leong, C.-C. Liu, A. Damiano, D. A. Wall, and Z. A. Cohn .
1986. Isolation and characterization of a serine esterase from cytolytic T cell granules.
Cell. 47:183.
22. Masson, D., M. Nabholz, C. Estrade, and J. Tschopp. 1986 . Granules of cytolytic T-
lymphocytes contain two serine esterases. EMBO (Eur. Mol. Biol. Organ.)l. 5:1595.138 2
￿
MEMBRANE BINDING AND LYTIC ACTIVITIES OF PERFORIN
23. Klompmakers, A. A., and T. Hendriks. 1986. A spectrophotometric microassay for
sulfated glycosaminoglycans using a laser densitometer. Anal. Biochem. 153:80.
24. Dvorak, A . M., S. J. Galli, J. A. Marcum, G. Nabel, H. D. Simonian, J. Goldin, R. A.
Monahan, K. Pyne, H. Cantor, R. D. Rosenberg, and H. F. Dvorak. 1983. Cloned
mouse cells with natural killer function and cloned suppressor T cells express
ultrastructural and biochemical features not shared by cloned inducer T cells.J. Exp.
Med. 157:843.
25. MacDermott, R. P., R. E. Schmidt, J. P. Caulfield, A. Hein, G. T. Bartley, J. Ritz, S.
F. Schlossman, K. F. Austen, and R. L. Stevens. 1985 . Proteoglycans in cell-mediated
cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate pro
teoglycan from human cloned natural killer cells during target cell lysis.J. Exp. Med.
162:1771 .
26. Schmidt, R . E., R. P. MacDermott, G. Bartley, M. Bertovich, D. A. Amato, K. F.
Austen, S. F. Schlossman, R. L. Stevens, and J. Ritz. 1985 . Specific release of
proteoglycans from human natural killer cells during target lysis. Nature (Lond.).
318:289.
27 . Tschopp, J., D. Masson, and S. Schafer. 1986. Inhibition of the lytic activity of
perforin by lipoproteins. J. Immunol. 137:1950.
28. Martz, E. 1977 . Mechanism of specific tumor-cell lysis by alloimmune T lymphocytes:
Resolution and characterization of discrete steps in the cellular interaction. Contemp.
Top. Immunobiol. 7 :301 .
29. Berke, G. 1983. Cytotoxic T-lymphocytes. How do they function? Immunol. Rev.
72 :5.
30. Young, J. D.-E., L. G. Leong, C.-C . Liu, A. Damiano, and Z. A. Cohn. 1986.
Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after
ionophore stimulation. Proc. Natl. Acad. Sci. USA. 83:5668.